BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Queensland Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,706,681

« Back to Dashboard

Which drugs does patent 6,706,681 protect, and when does it expire?

Patent 6,706,681 protects OVIDREL and is included in one NDA.

This patent has seventeen patent family members in fourteen countries.

Summary for Patent: 6,706,681

Title: HCG liquid formulations
Abstract:The invention refers to liquid pharmaceutical compositions containing hCG stabilised with a polyalcohol or a non-reducing sugar. Preferably, the compositions are stabilised with mannitol. In the preferred embodiments such compositions are aqueous solutions in a phosphate buffer at pH 7. Such compositions are ready to be injected and, therefore, the step of reconstitution of the lyophilised powder is avoided, thus simplifying the way of use.
Inventor(s): Samaritani; Fabrizio (Rome, IT), Natale; Patrizia (Rome, IT)
Assignee: Applied Research System ARS Holding N.V. (Antilles, NL)
Application Number:08/913,748
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Emd SeronoOVIDRELchoriogonadotropin alfaINJECTABLE;SUBCUTANEOUS021149-002Oct 6, 2003RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,706,681

PCT Information
PCT FiledMarch 21, 1997PCT Application Number:PCT/EP95/01055
PCT Publication Date:September 26, 1996PCT Publication Number: WO96/29095

International Patent Family for Patent: 6,706,681

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0814841► Subscribe
Spain2166841► Subscribe
Denmark0814841► Subscribe
Germany69524456► Subscribe
Australia707796► Subscribe
Brazil9510567► Subscribe
Finland973745► Subscribe
Australia2110695► Subscribe
Austria209930► Subscribe
Finland117160► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Chinese Patent Office
Farmers Insurance
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: